CLLS Valuation

Cellectis SA

Add to Watchlist

Advanced Chart

2.900

+0.05(1.754%)1D

Overview
Forecast
Valuation
Earnings

CLLS Relative Valuation

CLLS's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, CLLS is overvalued; if below, it's undervalued.

Historical Valuation

Cellectis SA (CLLS) is now in the Undervalued zone, suggesting that its current forward PS ratio of 5.68 is considered Undervalued compared with the five-year average of -2.08. The fair price of Cellectis SA (CLLS) is between 3.09 to 6.24 according to relative valuation methord. Compared to the current price of 2.90 USD , Cellectis SA is Undervalued By 6.15%.

Relative Value

Fair Zone

3.09-6.24

Current Price：2.90

6.15%

Undervalued

-2.55

Trailing

Forward

-2.59

EV/EBITDA

Cellectis SA. (CLLS) has a current EV/EBITDA of -2.59. The 5-year average EV/EBITDA is -2.89. The thresholds are as follows: Strongly Undervalued below -7.19, Undervalued between -7.19 and -5.04, Fairly Valued between -0.75 and -5.04, Overvalued between -0.75 and 1.40, and Strongly Overvalued above 1.40. The current Forward EV/EBITDA of -2.59 falls within the Historic Trend Line -Fairly Valued range.

-2.95

EV/EBIT

Cellectis SA. (CLLS) has a current EV/EBIT of -2.95. The 5-year average EV/EBIT is -2.50. The thresholds are as follows: Strongly Undervalued below -6.80, Undervalued between -6.80 and -4.65, Fairly Valued between -0.34 and -4.65, Overvalued between -0.34 and 1.81, and Strongly Overvalued above 1.81. The current Forward EV/EBIT of -2.95 falls within the Historic Trend Line -Fairly Valued range.

5.68

Cellectis SA. (CLLS) has a current PS of 5.68. The 5-year average PS is 5.98. The thresholds are as follows: Strongly Undervalued below -1.73, Undervalued between -1.73 and 2.13, Fairly Valued between 9.84 and 2.13, Overvalued between 9.84 and 13.70, and Strongly Overvalued above 13.70. The current Forward PS of 5.68 falls within the Historic Trend Line -Fairly Valued range.

-1.71

P/OCF

Cellectis SA. (CLLS) has a current P/OCF of -1.71. The 5-year average P/OCF is -2.39. The thresholds are as follows: Strongly Undervalued below -9.22, Undervalued between -9.22 and -5.81, Fairly Valued between 1.02 and -5.81, Overvalued between 1.02 and 4.43, and Strongly Overvalued above 4.43. The current Forward P/OCF of -1.71 falls within the Historic Trend Line -Fairly Valued range.

-2.70

P/FCF

Cellectis SA. (CLLS) has a current P/FCF of -2.70. The 5-year average P/FCF is -60.88. The thresholds are as follows: Strongly Undervalued below -566.07, Undervalued between -566.07 and -313.47, Fairly Valued between 191.72 and -313.47, Overvalued between 191.72 and 444.32, and Strongly Overvalued above 444.32. The current Forward P/FCF of -2.70 falls within the Historic Trend Line -Fairly Valued range.

Cellectis SA (CLLS) has a current Price-to-Book (P/B) ratio of 2.12. Compared to its 3-year average P/B ratio of 1.33 , the current P/B ratio is approximately 59.46% higher. Relative to its 5-year average P/B ratio of 1.68, the current P/B ratio is about 26.08% higher. Cellectis SA (CLLS) has a Forward Free Cash Flow (FCF) yield of approximately -16.46%. Compared to its 3-year average FCF yield of -27.49%, the current FCF yield is approximately -40.15% lower. Relative to its 5-year average FCF yield of -30.43% , the current FCF yield is about -45.92% lower.

2.12

P/B

Median3y

1.33

Median5y

1.68

-16.46

FCF Yield

Median3y

-27.49

Median5y

-30.43

Competitors Valuation Multiple

The average P/S ratio for CLLS's competitors is 18.94, providing a benchmark for relative valuation. Cellectis SA Corp (CLLS) exhibits a P/S ratio of 5.68, which is -69.98% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

China SXT Pharmaceuticals Inc

Tenaya Therapeutics Inc

Performance Decomposition

Market capitalization of CLLS increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00%to the performance.

Overall, the performance of CLLS in the past 1 year is driven by Unknown.